Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC
Jonathan R. George, Ying C. Henderson, Michelle D. Williams, et al.
The Journal of Clinical Endocrinology & Metabolism (2015) Vol. 100, Iss. 12, pp. E1550-E1559
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Understanding TERT Promoter Mutations: A Common Path to Immortality
Robert J.A. Bell, H. Tomas Rube, Ana Xavier‐Magalhães, et al.
Molecular Cancer Research (2016) Vol. 14, Iss. 4, pp. 315-323
Open Access | Times Cited: 261
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Muhammad Khairul Ramlee, Jing Wang, Wei Hong Toh, et al.
Genes (2016) Vol. 7, Iss. 8, pp. 50-50
Open Access | Times Cited: 139
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
Tiantian Liu, Xiaotian Yuan, Dawei Xu
Genes (2016) Vol. 7, Iss. 7, pp. 38-38
Open Access | Times Cited: 137
Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma
Sarika Rao, Mark Zafereo, Ramona Dadu, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 672-681
Open Access | Times Cited: 131
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
Miguel Melo, Adriana Gaspar da Rocha, Rui Batısta, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 6, pp. 1898-1907
Open Access | Times Cited: 125
Telomere Maintenance Mechanisms in Cancer
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, et al.
Genes (2018) Vol. 9, Iss. 5, pp. 241-241
Open Access | Times Cited: 113
TERT biology and function in cancer: beyond immortalisation
Ana Pestana, João Vinagre, Manuel Sobrinho‐Simões, et al.
Journal of Molecular Endocrinology (2017) Vol. 58, Iss. 2, pp. R129-R146
Open Access | Times Cited: 87
Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy
Hui Chen, Rajyalakshmi Luthra, Mark J. Routbort, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 7, pp. 1575-1584
Open Access | Times Cited: 75
Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma
Gregor Krings, Yunn‐Yi Chen
Modern Pathology (2018) Vol. 31, Iss. 11, pp. 1661-1674
Open Access | Times Cited: 72
Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis
Jing Yang, Yanping Gong, Shuping Yan, et al.
Endocrine (2019) Vol. 67, Iss. 1, pp. 44-57
Open Access | Times Cited: 70
TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas
Martyn Bullock, Yan Ren, Christine J. O’Neill, et al.
Clinical Endocrinology (2015) Vol. 85, Iss. 2, pp. 283-290
Open Access | Times Cited: 66
Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes
Gustavo Penna, Fernanda Vaisman, Mário Vaisman, et al.
Cytogenetic and Genome Research (2016) Vol. 150, Iss. 3-4, pp. 194-207
Open Access | Times Cited: 63
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
Heera Yang, Hyunju Park, Hyun Jin Ryu, et al.
Endocrinology and Metabolism (2022) Vol. 37, Iss. 4, pp. 652-663
Open Access | Times Cited: 30
BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
Jian Sun, Jing Zhang, Junliang Lu, et al.
PLoS ONE (2016) Vol. 11, Iss. 4, pp. e0153319-e0153319
Open Access | Times Cited: 58
TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors
Michiko Matsuse, Tomonori Yabuta, Vladimir Saenko, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 58
TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas
Aya Tanaka, Michiko Matsuse, Vladimir Saenko, et al.
Thyroid (2019) Vol. 29, Iss. 8, pp. 1105-1114
Open Access | Times Cited: 52
Co-existence of <em>BRAF<sup>V600E</sup></em> and <em>TERT </em>promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis
Haoyu Ren, Yifan Shen, Daixing Hu, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 1005-1013
Open Access | Times Cited: 50
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma
Claire Bournaud, Françoise Descôtes, Myriam Decaussin‐Petrucci, et al.
European Journal of Cancer (2019) Vol. 108, pp. 41-49
Open Access | Times Cited: 50
Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value ofTERTpromoter mutations and insignificant role ofBRAFmutations—a meta-analysis
Huy Gia Vuong, Ahmed Altibi, Uyen Duong, et al.
Tumor Biology (2017) Vol. 39, Iss. 10, pp. 101042831771391-101042831771391
Open Access | Times Cited: 41
<i>BRAF</i> and <i>TERT</i> promoter mutations: clinical application in thyroid cancer
Jae Hoon Chung
Endocrine Journal (2020) Vol. 67, Iss. 6, pp. 577-584
Open Access | Times Cited: 39
ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer
Martyn Bullock, Grace Lim, Ying Zhu, et al.
Thyroid (2019) Vol. 29, Iss. 11, pp. 1623-1633
Closed Access | Times Cited: 37
The Solo Play of TERT Promoter Mutations
François Hafezi, Danielle Perez-Bercoff
Cells (2020) Vol. 9, Iss. 3, pp. 749-749
Open Access | Times Cited: 37
Risk Factors for TERT Promoter Mutations with Papillary Thyroid Carcinoma Patients: A Meta-Analysis and Systematic Review
Jingxin Mao, Xingliang Huang, Mohammad K. Okla, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 19
Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis
Linh Hồ Thùy Nguyễn, Emma Thompson, Nazim Bhimani, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 939-939
Open Access
Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma
Jung Hyun Yoon, Kyunghwa Han, Eunjung Lee, et al.
PLoS ONE (2020) Vol. 15, Iss. 2, pp. e0228968-e0228968
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top